164 related articles for article (PubMed ID: 9692766)
1. Substance P blockade with the potent and centrally acting antagonist GR205171 does not effect central trigeminal activity with superior sagittal sinus stimulation.
Goadsby PJ; Hoskin KL; Knight YE
Neuroscience; 1998 Sep; 86(1):337-43. PubMed ID: 9692766
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of low dose CP122,288 and eletriptan on fos expression due to stimulation of the superior sagittal sinus in cat.
Goadsby PJ; Hoskin KL
Pain; 1999 Jul; 82(1):15-22. PubMed ID: 10422655
[TBL] [Abstract][Full Text] [Related]
3. Comparison of more and less lipophilic serotonin (5HT1B/1D) agonists in a model of trigeminovascular nociception in cat.
Hoskin KL; Goadsby PJ
Exp Neurol; 1998 Mar; 150(1):45-51. PubMed ID: 9514827
[TBL] [Abstract][Full Text] [Related]
4. Fos expression in the trigeminocervical complex of the cat after stimulation of the superior sagittal sinus is reduced by L-NAME.
Hoskin KL; Bulmer DC; Goadsby PJ
Neurosci Lett; 1999 May; 266(3):173-6. PubMed ID: 10465701
[TBL] [Abstract][Full Text] [Related]
5. Trigeminovascular nociceptive transmission involves N-methyl-D-aspartate and non-N-methyl-D-aspartate glutamate receptors.
Storer RJ; Goadsby PJ
Neuroscience; 1999; 90(4):1371-6. PubMed ID: 10338304
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of trigeminal neurones after intravenous administration of naratriptan through an action at 5-hydroxy-tryptamine (5-HT(1B/1D)) receptors.
Goadsby PJ; Knight Y
Br J Pharmacol; 1997 Nov; 122(5):918-22. PubMed ID: 9384509
[TBL] [Abstract][Full Text] [Related]
7. Central activation of the trigeminovascular pathway in the cat is inhibited by dihydroergotamine. A c-Fos and electrophysiological study.
Hoskin KL; Kaube H; Goadsby PJ
Brain; 1996 Feb; 119 ( Pt 1)():249-56. PubMed ID: 8624686
[TBL] [Abstract][Full Text] [Related]
8. Microiontophoretic application of serotonin (5HT)1B/1D agonists inhibits trigeminal cell firing in the cat.
Storer RJ; Goadsby PJ
Brain; 1997 Dec; 120 ( Pt 12)():2171-7. PubMed ID: 9448572
[TBL] [Abstract][Full Text] [Related]
9. The NMDA receptor antagonist MK-801 reduces Fos-like immunoreactivity within the trigeminocervical complex following superior sagittal sinus stimulation in the cat.
Classey JD; Knight YE; Goadsby PJ
Brain Res; 2001 Jul; 907(1-2):117-24. PubMed ID: 11430892
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of trigeminal neurons by intravenous administration of the serotonin (5HT)1B/D receptor agonist zolmitriptan (311C90): are brain stem sites therapeutic target in migraine?
Goadsby PJ; Hoskin KL
Pain; 1996 Oct; 67(2-3):355-9. PubMed ID: 8951929
[TBL] [Abstract][Full Text] [Related]
11. Selective blockade of substance P or neurokinin A receptors reduces the expression of c-fos in trigeminal subnucleus caudalis after corneal stimulation in the rat.
Bereiter DA; Bereiter DF; Tonnessen BH; Maclean DB
Neuroscience; 1998 Mar; 83(2):525-34. PubMed ID: 9460760
[TBL] [Abstract][Full Text] [Related]
12. The activity of GR205171, a potent non-peptide tachykinin NK1 receptor antagonist, in the trigeminovascular system.
Polley JS; Gaskin PJ; Perren MJ; Connor HE; Ward P; Beattie DT
Regul Pept; 1997 Jan; 68(1):23-9. PubMed ID: 9094751
[TBL] [Abstract][Full Text] [Related]
13. Serotonin inhibits trigeminal nucleus activity evoked by craniovascular stimulation through a 5HT1B/1D receptor: a central action in migraine?
Goadsby PJ; Hoskin KL
Ann Neurol; 1998 Jun; 43(6):711-8. PubMed ID: 9629840
[TBL] [Abstract][Full Text] [Related]
14. The role of 5-HT1B and 5-HT1D receptors in the selective inhibitory effect of naratriptan on trigeminovascular neurons.
Donaldson C; Boers PM; Hoskin KL; Zagami AS; Lambert GA
Neuropharmacology; 2002 Mar; 42(3):374-85. PubMed ID: 11897116
[TBL] [Abstract][Full Text] [Related]
15. The non-peptide neurokinin-1 antagonist, RPR 100893, decreases c-fos expression in trigeminal nucleus caudalis following noxious chemical meningeal stimulation.
Cutrer FM; Moussaoui S; Garret C; Moskowitz MA
Neuroscience; 1995 Feb; 64(3):741-50. PubMed ID: 7536309
[TBL] [Abstract][Full Text] [Related]
16. Patterns of fos expression in the rostral medulla and caudal pons evoked by noxious craniovascular stimulation and periaqueductal gray stimulation in the cat.
Knight YE; Classey JD; Lasalandra MP; Akerman S; Kowacs F; Hoskin KL; Goadsby PJ
Brain Res; 2005 May; 1045(1-2):1-11. PubMed ID: 15910757
[TBL] [Abstract][Full Text] [Related]
17. Expression of c-Fos-like immunoreactivity in the caudal medulla and upper cervical spinal cord following stimulation of the superior sagittal sinus in the cat.
Kaube H; Keay KA; Hoskin KL; Bandler R; Goadsby PJ
Brain Res; 1993 Nov; 629(1):95-102. PubMed ID: 8287282
[TBL] [Abstract][Full Text] [Related]
18. Attenuation of Fos-like immunoreactivity in the trigeminal nucleus caudalis following trigeminovascular activation in the anaesthetised guinea-pig.
Clayton JS; Gaskin PJ; Beattie DT
Brain Res; 1997 Nov; 775(1-2):74-80. PubMed ID: 9439830
[TBL] [Abstract][Full Text] [Related]
19. The 5-hydroxytryptamine1B/1D/1F receptor agonists eletriptan and naratriptan inhibit trigeminovascular input to the nucleus tractus solitarius in the cat.
Hoskin KL; Lambert GA; Donaldson C; Zagami AS
Brain Res; 2004 Feb; 998(1):91-9. PubMed ID: 14725972
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of the middle meningeal artery leads to Fos expression in the trigeminocervical nucleus: a comparative study of monkey and cat.
Hoskin KL; Zagami AS; Goadsby PJ
J Anat; 1999 May; 194 ( Pt 4)(Pt 4):579-88. PubMed ID: 10445825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
